Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab in the Management of Autoimmune Hepatitis
NCT06381453Phase 2Recruiting
- Sponsor
- University Health Network
- Start
- Dec 2024
- Primary completion
- Apr 2028
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of belimumab in autoimmune hepatitis (AIH), sponsored by University Health Network. Started Dec 2024; status: recruiting.
02
Drugs
belimumab
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on NCT06381453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06381453.